THEMIS MEDICARE
|
The Current P/E Ratio of THEMIS MEDICARE is -39.96.
| Share Price | ₹98.1 | May 05,2026 |
| Market Cap | ₹903.5 Cr | |
| Earnings-TTM | ₹-22.6 Cr | TTM-Consolidated Results |
| Price/Earnings | -39.96x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of THEMIS MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹903.5 Cr] as on May 05,2026
(/) Earnings [ ₹-22.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -39.96x ]
Thus, for THEMIS MEDICARE , the investors are currently willing to pay -39.96 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of THEMIS MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of THEMIS MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of THEMIS MEDICARE
PE Ratio Performance Analysis for THEMIS MEDICARE
- THEMIS MEDICARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.07x.
- THEMIS MEDICARE 's operated at median p/e ratio of 1.89x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, THEMIS MEDICARE 's p/e ratio peaked in Mar2024 at 46.31x.
- THEMIS MEDICARE 's p/e ratio hit its five-year low in Mar2021 of 0.72x.
How does THEMIS MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| THEMIS MEDICARE | -22.61 | -39.96 | 903.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 39.71 | 436,859.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 71.25 | 176,618.0 |
| CIPLA LTD | 4,544.70 | 23.70 | 107,722.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.70 | 144,718.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.26 | 106,081.0 |
| MANKIND PHARMA LTD | 1,796.65 | 53.32 | 95,803.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.60 | 91,753.5 |
| LUPIN LTD | 4,669.18 | 22.95 | 107,144.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 23.61 | 82,950.1 |
| ABBOTT INDIA LTD | 1,524.13 | 35.31 | 53,810.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs THEMIS MEDICARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -39.96x |
| Max industry PE | 71.25x |
| Median industry PE | 23.70x |
| Average industry PE | 30.13x |
You may also like the below Video Courses